These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23392270)

  • 1. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.
    Wong GK; Liang M; Tan H; Lee MW; Po YC; Chan KY; Poon WS
    Neurosurgery; 2013 May; 72(5):840-4. PubMed ID: 23392270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.
    Wong GK; Chan DY; Siu DY; Zee BC; Poon WS; Chan MT; Gin T; Leung M;
    Stroke; 2015 Feb; 46(2):382-8. PubMed ID: 25516195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis.
    Wong GK; Wong A; Zee BC; Poon WS; Chan MT; Gin T; Siu DY; Mok VC
    J Neurol Sci; 2015 Nov; 358(1-2):58-61. PubMed ID: 26285662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).
    Al-Tamimi YZ; Bhargava D; Feltbower RG; Hall G; Goddard AJ; Quinn AC; Ross SA
    Stroke; 2012 Mar; 43(3):677-82. PubMed ID: 22282887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.
    Saito I; Asano T; Sano K; Takakura K; Abe H; Yoshimoto T; Kikuchi H; Ohta T; Ishibashi S
    Neurosurgery; 1998 Feb; 42(2):269-77; discussion 277-8. PubMed ID: 9482177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Liu H; Xu X
    Am J Emerg Med; 2017 Dec; 35(12):1940-1945. PubMed ID: 28966073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
    Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC;
    Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Garg K; Sinha S; Kale SS; Chandra PS; Suri A; Singh MM; Kumar R; Sharma MS; Pandey RM; Sharma BS; Mahapatra AK
    Br J Neurosurg; 2013 Apr; 27(2):181-6. PubMed ID: 23298376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage.
    Liu Z; Liu L; Zhang Z; Chen Z; Zhao B
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008184. PubMed ID: 23633351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
    Lynch JR; Wang H; McGirt MJ; Floyd J; Friedman AH; Coon AL; Blessing R; Alexander MJ; Graffagnino C; Warner DS; Laskowitz DT
    Stroke; 2005 Sep; 36(9):2024-6. PubMed ID: 16051891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.
    Kirkpatrick PJ; Turner CL; Smith C; Hutchinson PJ; Murray GD;
    Lancet Neurol; 2014 Jul; 13(7):666-75. PubMed ID: 24837690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    Gathier CS; van den Bergh WM; van der Jagt M; Verweij BH; Dankbaar JW; Müller MC; Oldenbeuving AW; Rinkel GJE; Slooter AJC;
    Stroke; 2018 Jan; 49(1):76-83. PubMed ID: 29158449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Induced Hypertension on Cerebral Perfusion in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    Gathier CS; Dankbaar JW; van der Jagt M; Verweij BH; Oldenbeuving AW; Rinkel GJ; van den Bergh WM; Slooter AJ;
    Stroke; 2015 Nov; 46(11):3277-81. PubMed ID: 26443829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial.
    da Costa BBS; Windlin IC; Koterba E; Yamaki VN; Rabelo NN; Solla DJF; Teixeira MJ; Figueiredo EG
    Trials; 2019 Jul; 20(1):413. PubMed ID: 31288831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).
    Leijenaar JF; Dorhout Mees SM; Algra A; van den Bergh WM; Rinkel GJ;
    Int J Stroke; 2015 Oct; 10 Suppl A100():108-12. PubMed ID: 26502971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.